Literature DB >> 15671027

Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes.

Xuyang Peng1, Xinxin Guo, Steven C Borkan, Ajit Bharti, Yukio Kuramochi, Stuart Calderwood, Douglas B Sawyer.   

Abstract

Heat shock protein (Hsp) 90 is a ubiquitously expressed chaperone that stabilizes expression of multiple signaling kinases involved in growth regulation, including ErbB2, Raf-1, and Akt. The chaperone activity of Hsp90 requires ATP, which binds with approximately 10-fold lower affinity than ADP. This suggests that Hsp90 may be a physiological ATP sensor, regulating the stability of growth signaling cascades in relation to cellular energy charge. Here we show that lowering ATP concentration by inhibiting glycolysis or mitochondrial respiration in isolated myocytes triggers rapid dissociation of Hsp90 from ErbB2 and degradation of ErbB2 along with other client proteins. The effect of disrupting Hsp90 chaperone activity by ATP depletion was similar to the effect of the pharmacological Hsp90 inhibitor geldanamycin. ATP depletion-induced disruption of Hsp90 chaperone activity was associated with cellular resistance to growth factor activation of intracellular signaling. ErbB2 degradation was also induced by the physiological stress of beta-adrenergic receptor stimulation in electrically stimulated cells. These results support a role for Hsp90 as an ATP sensor that modulates tissue growth factor responsiveness under metabolically stressed conditions and provide a novel mechanism by which cellular responsiveness to growth factor stimulation is modulated by cellular energy charge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671027     DOI: 10.1074/jbc.M410838200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

2.  Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.

Authors:  Matthew Zeglinski; Ana Ludke; Davinder S Jassal; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2011

3.  Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes.

Authors:  Laura Pentassuglia; Michael Graf; Heidi Lane; Yukio Kuramochi; Gregory Cote; Francesco Timolati; Douglas B Sawyer; Christian Zuppinger; Thomas M Suter
Journal:  Exp Cell Res       Date:  2009-02-12       Impact factor: 3.905

4.  Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells.

Authors:  Abbes Belkhiri; Altaf A Dar; Dun Fa Peng; Mohammad H Razvi; Cammie Rinehart; Carlos L Arteaga; Wael El-Rifai
Journal:  Clin Cancer Res       Date:  2008-06-25       Impact factor: 12.531

Review 5.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

Review 6.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

7.  Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes.

Authors:  M T Nguyen; P Csermely; C Sőti
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

8.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

Review 9.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

10.  Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy.

Authors:  Shensi Shen; Pengtao Zhang; Martin A Lovchik; Ying Li; Liuya Tang; Zhimin Chen; Rong Zeng; Dawei Ma; Junying Yuan; Qiang Yu
Journal:  J Cell Biol       Date:  2009-05-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.